The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Subject File, 1902-2012 (continued)
1980-1999, undated (continued)
(5 folders)
BOX II:152 General
BOX II:152 1902, 1918, 1928, 1934-1939, 1951-1961
(2 folders)
BOX II:153 1962-1964
(7 folders)
BOX II:154 1965-1974
(7 folders)
BOX II:155 1975-2005, undated
(7 folders)
BOX II:155 Micro-Dynameters and other topics, press coverage, 1962
BOX II:156 “News Items,” 1962
(2 folders)
BOX II:156 History competitions, requests for information and interviews, 1971, 1989-1999, undated
(2 folders)
BOX II:156 Homeopathy, 1962-1963, 1989-1997
BOX II:156 Hydrazine sulfate, 1976-1980, 1995-2000
BOX II:156 Hyperthermia and birth defects, 1966, 1973, 1980-1983, undated
BOX II:156 Hypoglycemic oral agents, 1963-1971, 1976-1984, 1998-2000
BOX II:157 Imipramine, 1963, 1969-1976, 1986
BOX II:157 Indocin, 1966, 2000
BOX II:157 Industrial Bio-Test Laboratories, Northbrook, Ill., 1977-1983, 2000-2001
BOX II:157 Influenza epidemic of 1918, 1982, 1997-2001
BOX II:157 Informed consent and patient consent See Containers II:157-II:164, Institutional review boards and consent
BOX II:157 Insecticides See Container II:186, Pesticides and environmental hazards
BOX II:157 Institutional review boards and consent
BOX II:157 Articles and clippings
BOX II:157 1961-1993
(5 folders)
BOX II:158 1996-2000, undated
(3 folders)
BOX II:158 Deferred consent, 1990-1993, undated
(2 folders)
BOX II:158 General
BOX II:158 1962-1973
(5 folders)
BOX II:159 1974-1983
(8 folders)
BOX II:160 1984-1996
(10 folders)
BOX II:161 1997-2000, undated
(6 folders)
BOX II:161 Guidance for IRBs and Clinical Investigators, 1998
BOX II:161 IRB Re-Engineering Task Force and subcommittees, U.S. Food and Drug Administration
BOX II:161 1998
(2 folders)
BOX II:162 (5 folders)
BOX II:162 2000
BOX II:162 Mariposa Foundation, 1988-1990, undated
BOX II:162 Memoranda with National Institutes of Health, 1973-1974, 2000, undated
BOX II:163 Miscellaneous workshops, 2001, undated
BOX II:163 Notes, 1999
BOX II:163 Patient follow-up, 1973-1974, 1982-1983
BOX II:163 Patient interviews and records, 1979-1981, 2000, undated
BOX II:163 Reports
BOX II:163 Advisory Committee on Human Radiation Experiments, circa 1995
BOX II:163 General, 1976-1983, 1994-1996
(3 folders)
BOX II:164 Research Involving Human Subjects Committee, 1983, 1989, 1999-2000, undated
BOX II:164 Seeding trials, 1987-1988
BOX II:164 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
BOX II:164 1987-1990
(5 folders)
BOX II:164 1991
(2 folders)
BOX II:165 (1 folder)
BOX II:165 1992
(4 folders)
BOX II:165 1993
BOX II:165 Jan.
BOX II:165 Feb.
(2 folders)
BOX II:166 (2 folders)
BOX II:166 Mar.-Sept.
(6 folders)
BOX II:167 Oct.-Nov.
(3 folders)
BOX II:167 1994-1997, 2000-2001, undated
(3 folders)
BOX II:167 International Research and Development Corp., 1978, 1986-1991, 1996-1999
(1 folder)
BOX II:168 (1 folder)
BOX II:168 Investigational Drug Branch, U.S. Food and Drug Administration, 1960-1967, undated
BOX II:168 Investigational new drugs (INDs)
BOX II:168 Charges for, 1982-1987, 1995
BOX II:168 Differences in opinion during IND/New Drug Application processes, 1979
BOX II:168 IND cover sheet and BIMO data collection sheet, 1974-1979
(2 folders)
BOX II:168 Miscellany, 1964-1965, 1996-1997
BOX II:168 Outline submitted to Goddard, 1967
BOX II:168 Revision of IND and NDA regulations, 1974
BOX II:168 Rewrite, 1984
BOX II:168 Isoniazid, 1960-1974, undated
BOX II:168 Jolly, Eugene Richard, 1958, 1975-1976, 1982-1986, 1998-1999, undated
BOX II:168 Kerlan, Irvin, 1958-1961, 1966, 1997, undated
BOX II:168 Krebiozen, 1953, 1962-1966, 1984, 1999
BOX II:169 Laetrile
BOX II:169 General, 1977-1982, 1997-2000
BOX II:169 Testimony of Kelsey, 1979
BOX II:169 Ley, Herbert L., questions for interview, 1967-circa 1968, 1998
BOX II:169 Librium and valium, 1960-1990, undated
(2 folders)
BOX II:169 Lithium, 1966-1972, 1975-1986, undated
BOX II:169 Livingston lysate, 1969
BOX II:169 Lotronex (Alosetron), 2000-2002
BOX II:169 LSD (Drug), 1963, 1969-1971, 1977, 1996-1999
BOX II:169 Male role in fertility and birth defects, 1952, 1962-1972, 1978-1981, 1987-1989, 1998, undated
BOX II:169 Marine pharmacology, 1969-1991, 1998-2001, undated
BOX II:169 Marrazzi, Amedeo S., 1975-1976, 1999, undated
BOX II:170 Maternal-Child Problems Task Force See also Container II:100, Bendectin
BOX II:170 1979-1981
(6 folders)
BOX II:170 1982
(1 folder)
BOX II:171 (2 folders)
BOX II:171 1983, 1996, undated
(3 folders)
BOX II:171 Memoranda of understanding
BOX II:171 Defense Department, investigational new drugs, 1969, 1974-1981, 1986-1987, 1997-1998
(2 folders)
BOX II:171 General, 1971-1975, 1982-1988, 1998, undated
BOX II:171 National Institutes of Health, 1975-1981
BOX II:172 New York Department of Health, 1978-1979
BOX II:172 Veteran’s Administration, 1977-1984
BOX II:172 Mercury, 1968-1987, 1996, undated
Next Page »

Contents List